1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Dry Eye Products Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Dry Eye Products Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Dry Eye Products Market Regional Analysis
6.2 Europe Dry Eye Products Market Revenue 2021-2031 (US$ Million)
6.3 Europe Dry Eye Products Market Forecast Analysis
7. Europe Dry Eye Products Market Analysis – by Product
7.1 Artificial Tears
- 7.1.1 Overview
- 7.1.2 Artificial Tears: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Anti-Inflammatory Drugs
- 7.2.1 Overview
- 7.2.2 Anti-Inflammatory Drugs: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Punctal Plugs
- 7.3.1 Overview
- 7.3.2 Punctal Plugs: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Secretagogues
- 7.4.1 Overview
- 7.4.2 Secretagogues: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Oral Omega Supplements
- 7.5.1 Overview
- 7.5.2 Oral Omega Supplements: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Dry Eye Products Market Analysis – by Dosage Form
8.1 Eye Drops
- 8.1.1 Overview
- 8.1.2 Eye Drops: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Gel
- 8.2.1 Overview
- 8.2.2 Gel: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Capsules
- 8.3.1 Overview
- 8.3.2 Capsules: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Tablets
- 8.4.1 Overview
- 8.4.2 Tablets: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Dry Eye Products Market Analysis – by Type
9.1 OTC
- 9.1.1 Overview
- 9.1.2 OTC: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Prescription: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Dry Eye Products Market Analysis – by Distribution Channel
10.1 Retail Pharmacy
- 10.1.1 Overview
- 10.1.2 Retail Pharmacy: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Hospital Pharmacy
- 10.2.1 Overview
- 10.2.2 Hospital Pharmacy: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Online Pharmacy
- 10.3.1 Overview
- 10.3.2 Online Pharmacy: Europe Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Europe Dry Eye Products Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Dry Eye Products Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 Europe Dry Eye Products Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 UK: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.1.2 UK: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.1.3 UK: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.1.4 UK: Europe Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.2 Germany:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Germany: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.2.2 Germany: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.2.3 Germany: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.2.4 Germany: Europe Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.3 France:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 France: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.3.2 France: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.3.3 France: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.3.4 France: Europe Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.4 Russia:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.4.1 Russia: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.4.2 Russia: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.4.3 Russia: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.4.4 Russia: Europe Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.5 Italy:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.5.1 Italy: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.5.2 Italy: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.5.3 Italy: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.5.4 Italy: Europe Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.6 Rest of Europe:
Europe Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Dry Eye Products Market Breakdown, by Product
- 11.2.1.6.2 Rest of Europe: Europe Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.6.3 Rest of Europe: Europe Dry Eye Products Market Breakdown, by Type
- 11.2.1.6.4 Rest of Europe: Europe Dry Eye Products Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Santen Pharmaceutical Co Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Johnson & Johnson
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 OASIS Medical
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 URSAPHARM Arzneimittel GmbH
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Rohto Pharmaceutical Co Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 OCuSOFT Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bausch Health Companies Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 AbbVie Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Prestige Consumer Healthcare Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Farmigea SpA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Alcon AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations